CommercialPrior AuthHigh impact
Cerebrovascular Angioplasty, Stenting, and Select Surgical Procedures (CPB 0276, reviewed 2026-06-05)
Aetna·Neurology, Neurosurgery, Vascular Surgery +2 more·Surgery
Effective date
Jun 5, 2026
We identified it
Aug 14, 2026
Summary
Aetna's CPB 0276 (reviewed 2026-06-05) establishes updated medical necessity criteria for cerebrovascular angioplasty, stenting, and surgical procedures, including specific requirements for carotid artery stenting (CAS) with embolic protection, carotid endarterectomy (CEA), intracranial aneurysm repair, and treatment of cerebral vasospasm. The policy also clarifies that certain procedures (extracranial vertebral artery stenting for asymptomatic stenosis, drug-eluting stents for extracranial arteries, and most intracranial angioplasty/stenting) remain experimental/investigational.
Action Required
By 2026-06-05: Billing team must update claims processing rules and prior authorization workflows to enforce Aetna's updated medical necessity criteria for cerebrovascular procedures (CPB 0276). Specifically: (1) For carotid artery stenting (CPT 37215, 37216, 37217, 37218), require documentation of symptomatic stenosis ≥50% OR asymptomatic ≥70%, completed duplex ultrasound, CTA/MRA confirmation, and neurologist assessment with NIHSS certification before and after procedure; (2) Update prior auth templates to verify discussion of all treatment options (CEA, TFCAS, TCAR, medical therapy) with documented risks/benefits; (3) Flag claims for carotid revascularization in patients with modified Rankin scale ≥3 (disabling stroke) for denial per policy; (4) Deny all claims for extracranial vertebral artery stenting for asymptomatic stenosis (0075T, 0076T) as experimental/investigational; (5) Deny intracranial angioplasty/stenting (CPT 61630, 61635, 61640, 61641, 61642) when coded for prophylaxis or atherosclerotic stenosis without dual diagnosis of subarachnoid hemorrhage AND ischemia; (6) Update encounter forms and provider alerts to highlight documentation requirements; (7) Providers and billing staff should reference related policies CPB 0621 (Drug-Eluting Stents), CPB 0785 (Endovascular Arterial and Venous Stent Procedures), CPB 0789 (Acute Ischemic Stroke Treatments). Failure to enforce these criteria will result in claim denials and potential rework.